Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Mar;47(3):616-617.
doi: 10.1111/ced.15006. Epub 2021 Dec 10.

Risankizumab-induced paradoxical pustular psoriasis

O McFeely  1 , E Pender  1 , L Victory  1 , H Almutlaq  1   2 , E Storan  1
Affiliations
Case Reports

Risankizumab-induced paradoxical pustular psoriasis

O McFeely et al. Clin Exp Dermatol. 2022 Mar.

Abstract

A 45-year-old white woman established on risankizumab self-presented to our service with pustular psoriasis affecting 60% of her body surface area. No history of pustular psoriasis was described in the 22 years that she had been diagnosed with psoriasis. This, to our knowledge, is the first case of paradoxical pustular psoriasis associated with risankizumab.

PubMed Disclaimer

References

    1. Murphy MJ, Cohen JM, Vesely MD, Damsky W. Paradoxical eruptions to targeted therapies in dermatology: a systematic review and analysis. J Am Acad Dermatol 2020. https://doi.org/10.1016/j.jaad.2020.12.010. in press.
    1. Blauvelt A, Leonardi CL, Gooderham M et al. Efficacy and safety of continuous risankizumab therapy vs treatment withdrawal in patients with moderate to severe plaque psoriasis: a phase 3 randomized clinical trial. JAMA Dermatol 2020; 156: 649-58.
    1. Puig L. Paradoxical reactions: anti-tumor necrosis factor alpha agents, ustekinumab, secukinumab, ixekizumab, and others. Curr Probl Dermatol 2018; 53: 49-63.
    1. Kashlan R, Slater K, Garber ME, Kartono F. Paradoxical psoriatic arthritis flare with the initiation of brodalumab and guselkumab. JAAD Case Rep 2021; 10: 47-9.

MeSH terms